Two new RSV vaccine candidates, made by Pfizer and GlaxoSmithKline, could become the world’s first approved shots against the common respiratory syncytial virus (RSV). The FDA, which typically follows the committee’s recommendations, is expected to decide on approval in May, ahead of RSV’s typical winter surge.
Source: www.cnn.com
Related posts:
SF Giants bolster rotation again, sign another veteran starter
Warriors make a statement with win over Brooklyn, Kevin Durant
Gov. Gavin Newsom roasted for telling Disney to 'bring jobs back' to California: 'Good luck with tha...
Sam Bankman-Fried’s latest Stanford guest blasts ‘sexualized’ coverage of her house-arrest visit
Photos: Bay Area high school football Week 9, 2022